Chugai Pharmaceutical Co., Ltd. (TYO:4519)
Japan flag Japan · Delayed Price · Currency is JPY
6,131.00
-124.00 (-1.98%)
Aug 14, 2025, 3:30 PM JST

Chugai Pharmaceutical Revenue

Chugai Pharmaceutical had revenue of 290.01B JPY in the quarter ending June 30, 2025, a decrease of -8.20%. This brings the company's revenue in the last twelve months to 1.20T, up 10.29% year-over-year. In the year 2024, Chugai Pharmaceutical had annual revenue of 1.17T with 5.33% growth.

Revenue (ttm)
1,196.22B
Revenue Growth
+10.29%
P/S Ratio
8.61
Revenue / Employee
238.01M
Employees
5,026
Market Cap
10.29T

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20241,170.61B59.24B5.33%
Dec 31, 20231,111.37B-148.58B-11.79%
Dec 31, 20221,259.95B260.19B26.02%
Dec 31, 2021999.76B212.81B27.04%
Dec 31, 2020786.95B100.76B14.68%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Takeda Pharmaceutical Company 4,480.25B
HOYA Corporation 876.09B
Daiichi Sankyo Company 1,924.68B
Otsuka Holdings 2,401.70B
Terumo 1,037.94B
Astellas Pharma 1,944.99B
Shionogi & 440.50B
Olympus 969.02B
Revenue Rankings